drugset / Trial / NCT07561645
A Trial for the Treatment of Advanced Large-Cell Neuroendocrine Cancer of the Lung
NaSingle-groupOpen-labelTreatment
Summary
This phase II clinical trial evaluates the efficacy, safety and tolerability of Obrixtamig in addition to standard of care chemotherapy (Platinum/Etoposide) in LCNEC.
Timeline
- Start
- 2026-07
- Primary completion
- 2032-04
- Completion
- 2032-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Obrixtamig | Other / unclassified | — | — |